+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

North America Microfluidics Market Forecast to 2027 - COVID-19 Impact and Country Analysis - by Product, Material, Application; and Country

  • PDF Icon

    Report

  • 126 Pages
  • August 2020
  • Region: North America
  • The Insight Partners
  • ID: 5138165
UP TO OFF until Dec 31st 2024
The North America microfluidics market was valued at US$ 4,901.47 million in 2019 and is projected to reach US$ 18,301.24 million by 2027; it is expected to grow at a CAGR of 18.2% during 2020–2027.

The growth of the microfluidics market is mainly attributed to the factors such as the increasing adoption of microfluidics technologies in point-of-care testing, and technological advancement in microfluidics. However, the challenges involved in product commercialization are the major factors hindering the market growth.

Microfluidics involves processing or manipulation of small amount of fluidics. It studies various systems that can process small quantities of fluids by using tiny channels having dimensions in micrometers. Microfluidics is an emerging technology having a wide range of applications in biology, chemistry, optics and information technology. This technology is widely used for various processes such as capillary electrophoresis, sample injection in mass spectrometry, immunoassays, flow cytometry, DNA analysis, separation and manipulation of cells, and PCR amplification. Additionally, microfluidics is also used in the diagnosis of cancer and for other research work.

The increasing technological advancements in diagnostic devices and the rising incidence of chronic diseases are augmenting the adoption of microfluidics in disease diagnosis. The market is witnessing numerous product launches along with technological advancements in microfluidics, such as 3D lab-on-a-chip devices. Moreover, key market players have been introducing new products to strengthen their market position. For instance, in January 2020, Nicoya launched the Alto surface plasmon resonance (SPR) system. It is the first fully-automated, high-throughput system that integrates digital microfluidics (DMF), artificial intelligence (AI), and nanotechnology, which offers high quality, label-free interaction analysis. This product is designed to reduce the time and cost of drug discovery. These technological advancements are expected to propel the growth of the market during the forecast period.

COVID-19 has affected the North American countries which has led to a high number of COVID-19 cases in the region. Microfluidics has gained a lot of attention with respect to the diagnosis of COVID-19. For instance, US-based researchers from Broad Institute have developed a CRISPR-based molecular diagnostics stage with the help of microfluidics chips to detect viruses in human samples. This single chip has the potential to detect a single virus in more than 1,000 samples at a time.

Based on product, the microfluidics market is segmented into microfluidic chips, microfluidic sensors, devices, micro pumps, micro needles and other products. The devices segment held the largest share of the market in 2019. However, the market for microfluidic chips is estimated grow at the highest CAGR in the market during the forecast period.

Based on material, the market is segmented into PDMS, polymers, glass, silicon, and other materials. Based on application, the market is segmented into in vitro diagnostics, pharmaceutical and life science research, drug discovery, and other applications. Further, the in vitro diagnostic segment is sub segmented into point-of-care testing (POC) and clinical diagnostic.

The World Health Organization (WHO), World Heart Federation, National Center for Biotechnology Information, along with company websites, are among the major primary and secondary sources referred for preparing this report.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Microfluidics Market - By Product
1.3.2 North America Microfluidics Market - By Material
1.3.3 North America Microfluidics Market - By Application
1.3.4 North America Microfluidics Market- By Region
2. Microfluidics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Microfluidics - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America
4.3 Expert Opinion
5. North America Microfluidics Market - Industry Dynamics
5.1 Market Drivers
5.1.1 Growing Market for Microfluidics Technologies in Point-Of-Care Testing
5.1.2 Technological Advancement in Microfluidics Product
5.2 Market Restraints
5.2.1 Challenges In Product Commercialization
5.3 Market Opportunities
5.3.1 Increasing Application of Microfluidics in Drug Discovery
5.4 Future Trends
5.4.1 3D Printing in Microfluidics
5.5 Impact Analysis
6. Microfluidics Market - Regional Analysis
6.1 North America Microfluidics Market Revenue Forecast And Analysis
7. North America Microfluidics Market Analysis - By Product Type
7.1 Overview
7.2 Microfluidics Market Revenue Share, by Product (2019 and 2027)
7.3 Microfluidic Chips
7.3.1 Overview
7.3.2 Microfluidic Chips: Microfluidics Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Microfluidic Sensors
7.4.1 Overview
7.4.2 Microfluidic Sensors: Microfluidics Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Micropumps
7.5.1 Overview
7.5.2 Micropumps: Microfluidics Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Microneedles
7.6.1 Overview
7.6.2 Microneedles: Microfluidics Market - Revenue and Forecast to 2027 (US$ Million)
7.7 Devices
7.7.1 Overview
7.7.2 Devices: Microfluidics Market - Revenue and Forecast to 2027 (US$ Million)
7.8 Other Products
7.8.1 Overview
7.8.2 Other Products: Microfluidics Market - Revenue and Forecast to 2027 (US$ Million)
8. Microfluidics Market Analysis, by Material
8.1 Overview
8.2 Microfluidics Market Revenue Share, by Material (2019 and 2027)
8.3 Polymers
8.3.1 Overview
8.3.2 Polymers: Microfluidics Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Glass
8.4.1 Overview
8.4.2 Glass: Microfluidics Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Silicon
8.5.1 Overview
8.5.2 Silicon: Microfluidics Market - Revenue and Forecast to 2027 (US$ Million)
8.6 PDMS (Polydimethylsiloxane)
8.6.1 Overview
8.6.2 PDMS (Polydimethylsiloxane): Microfluidics Market - Revenue and Forecast to 2027 (US$ Million)
8.7 Other Materials
8.7.1 Overview
8.7.2 Other Materials: Microfluidics Market - Revenue and Forecast to 2027 (US$ Million)
9. Microfluidics Market Analysis, by Application
9.1 Overview
9.2 Microfluidics Market Revenue Share, by Application (2019 and 2027)
9.3 In Vitro Diagnostics
9.3.1 Overview
9.3.2 In Vitro Diagnostics: Microfluidics Market - Revenue and Forecast to 2027 (US$ Million)
9.3.3 Point-of-Care Testing
9.3.3.1 Overview
9.3.3.2 Point of Care Testing (POCT) Market: Microfluidics Market- Revenue and Forecast to 2027 (US$ Million)
9.3.4 Clinical Diagnostics
9.3.4.1 Overview
9.3.4.2 Clinical Diagnostics: Microfluidics Market- Revenue and Forecast to 2027 (US$ Million)
9.4 Pharmaceutical and Life Science Research
9.4.1 Overview
9.4.2 Pharmaceutical and Life Science Research: Microfluidics Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Drug Discovery
9.5.1 Overview
9.5.2 Drug Discovery: Microfluidics Market - Revenue and Forecast to 2027 (US$ Million)
9.6 Other Applications
9.6.1 Overview
9.6.2 Other Applications: Microfluidics Market - Revenue and Forecast to 2027 (US$ Million)
10. Microfluidics Market - Geographic Analysis
10.1 North America: Microfluidics Market
10.1.1 Overview
10.1.2 North America: Microfluidics Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Microfluidics Market, by Product, 2018-2027 (USD Million)
10.1.4 North America: Microfluidics Market, by Material, 2018-2027 (USD Million)
10.1.5 North America: Microfluidics Market, by Application, 2018-2027 (USD Million)
10.1.5.1 North America: Microfluidics Market, by In Vitro Diagnostics, 2018-2027 (USD Million)
10.1.6 North America: Microfluidics Market, by Country, 2019& 2027 (%)
10.1.7 US: Microfluidics Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Microfluidics Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Microfluidics Market, by Product, 2018-2027 (USD Million)
10.1.7.3 US: Microfluidics Market, by Material, 2018-2027 (USD Million)
10.1.7.4 US: Microfluidics Market, by Application, 2018-2027 (USD Million)
10.1.7.4.1 US: Microfluidics Market, by In Vitro Diagnostics, 2018-2027 (USD Million)
10.1.8 Canada: Microfluidics Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Microfluidics Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Microfluidics Market, by Product, 2018-2027 (USD Million)
10.1.8.3 Canada: Microfluidics Market, by Material, 2018-2027 (USD Million)
10.1.8.4 Canada: Microfluidics Market, by Application, 2018-2027 (USD Million)
10.1.8.4.1 Canada: Microfluidics Market, by In Vitro Diagnostics, 2018-2027 (USD Million)
10.1.9 Mexico: Microfluidics Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Microfluidics Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Microfluidics Market, by Material, 2018-2027 (USD Million)
10.1.9.3 Mexico: Microfluidics Market, by Application, 2018-2027 (USD Million)
10.1.9.3.1 Mexico: Microfluidics Market, by In Vitro Diagnostics, 2018-2027 (USD Million)
11. Impact Of COVID-19 Pandemic On Global Microfluidics Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Microfluidics Market -Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic and Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Danaher
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Perkin Elmer, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.5 BIO-RAD LABORATORIES INC.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Agilent Technologies, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Fludigm Corporation
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Illumina, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 BD
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix

Companies Mentioned

  • Agilent Technologies, Inc.,
  • BD
  • Bio-Rad Laboratories Inc.